170555 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Oxidoreductases (1.) acting on NADH or NADPH (1.6), e.g. those with a heme protein as acceptor (1.6.2) (general), Cytochrome-b5 reductase (1.6.2.2) or NADPH-cytochrome P450 reductase (1.6.2.4)
Frozen Biofluids Mitochondrial Bioenergetics Function Assessment Method for Traumatic Brain Injury and Polytrauma
#2DIAGNOSIS AND/OR TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
#3BIOMARKER FOR PREDICTING THE PROGNOSIS OF COLORECTAL CANCER
#4METHOD AND COMPOSITION FOR STABILISING NICOTINAMIDE ADENINE DINUCLEOTIDE
#5METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#6METHOD FOR THE DIAGNOSIS AND TREATMENT OF ESSENTIAL PRIMARY HYPERTENSION
#7Compositions and methods to regulate Renalase in the treatment of cancer
#8BIOMARKERS PREDICTIVE OF CANCER CELL RESPONSE TO ML329 OR A DERIVATIVE THEREOF
#9METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#10Compositions and methods to regulate Renalase in the treatment of cancer
#11Methods for measuring Renalase
#12Diagnosis and therapy of multiple sclerosis
#13MICROSOMES IRREVERSIBLY INHIBITED FOR CYP450 THEIR USES IN THE PHENOTYPING OF ENZYMATIC METABOLIC PATHWAYS
#14NADPH oxidase proteins
#15METHODS AND COMPOSITIONS FOR SINGLE CHAIN VARIABLE REGION ENOX2 ANTIBODIES FOR CANCER DETECTION AND DIAGNOSIS
#16NRF2 Screening Assays and Related Methods and Compositions
#17Compositions and methods for treating and preventing pancreatitis, renal injury and cancer
#18STEAP3 as a biochemical marker of red blood cell storage and toxicity
#19Antibody to Renalase
#20Method for measuring protein and nucleic acid with ultrahigh sensitivity
#21Compositions and methods for detecting, treating and preventing diseases and disorders
#22METHOD FOR MANUFACTURING A MICROBIAL DETECTION DEVICE, MICROBIAL DETECTION METHOD, MICROBIAL DETECTION KIT, AND MICROBIAL DETECTION DEVICE
#23Advanced detection of sepsis
#24NRF2 Screening Assays and Related Methods and Compositions
#25Methods and reagents for analyzing protein-protein interfaces
#26Methods and reagents for analyzing protein-protein interfaces
#27Methods of diagnosing and treating cancer comprising ME1
#28Ultra-high-sensitive assay of protein and nucleic acid and kit, and novel enzyme substrate
#29Advanced detection of sepsis
#30Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#31Compositions and methods for performing assays
#32Steap3 as a biochemical marker of red blood cell storage and toxicity
#33Compositions to regulate renalase in the treatment of diseases and disorders
#34Methods and reagents for analyzing protein-protein interfaces
#35NADPH oxidase proteins
#36Method for manufacturing a microbial detection device, microbial detection method, microbial detection kit, and microbial detection device
#37Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#38Methods for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#39Diagnosis and therapy of multiple sclerosis
#40Systems and methods for electrochemical ketone detection and measurement
#41METHOD FOR DETECTING FLUORESCENCE OR ABSORBANCE, METHOD FOR SUPPRESSING BACKGROUND, METHOD FOR MEASURING ADP, METHOD FOR MEASURING ACTIVITY OF ADP-SYNTHESIZING ENZYME, AND METHOD FOR MEASURING ACTIVITY OF GLUCOSYLTRANSFERASE
#42Pharmaceutical composition for preventing and treating cancer, containing CYB5R3 gene or protein as active ingredient
#43Advanced detection of sepsis
#44Glycine, Mitochondrial One-Carbon Metabolism, and Cancer
#45Methods for novel drug discovery, treatment and selective targeting for gefitinib-resistant non-small-cell lung cancer harboring T790M mutation
#46Compositions and methods for detecting, treating and preventing diseases and disorders
#47MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#48INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN
#49METHODS AND COMPOUNDS FOR DETECTING CANCER
#50Pharmaceutical compositions comprising small interfering RNA inhibitors of NOX3
#51Advanced detection of sepsis
#52Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis
#53Ultra-high-sensitive assay of protein and nucleic acid and kit, and novel enzyme substrate
#54Single-pad strip for an improved lateral flow assay and a test device using the same
#55Cloning and Expression of arNOX Protein Transmembrane 9 Superfamily (TM9SF), Methods and Utility
#56METHOD AND KIT FOR MEASURING ENZYMATIC ACTIVITIES OF VARIOUS CYTOCHROME P450 MOLECULE SPECIES COMPREHENSIVELY AND WITH HIGH EFFICIENCY
#57Treatment for Amyotrophic Lateral Sclerosis
#58Means and methods for the treatment of hearing loss and phantom hearing
#59Treatment for multiple sclerosis
#60IN VITRO METHOD FOR DETECTING GP91PHOX AS A MARKER OF OXIDATIVE STRESS
#61METHOD FOR TREATING LUNG DISEASE
#62Vaginal indicator to detect biomarkers of good health
#63Combination Treatment of Breast Cancer
#64Methods for the Detection and Treatment of Aberrant Prion Disease
#65Kit for positively detecting toxic material
#66BREAST CANCER PROGNOSTICS
#67Treatment prediction involving HMGCR
#68Advanced detection of sepsis
#69NRF2 SCREENING ASSAYS AND RELATED METHODS AND COMPOSITIONS
#70METHOD OF DETERMINATION OF PDH ACTIVITY AND IMAGING MEDIA FOR USE IN SAID METHOD
#71ASSESSING TREATMENT COMPLIANCE
#72Autoimmune conditions and NADPH oxidase defects
#73Expression quantification using mass spectrometry
#74Nitroreductase enzymatic substrates
#75Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease
#76USES OF THIOREDOXIN
#77METHOD FOR PREDICTING THE RESPONSE TO A THERAPY
#78Means and methods of using a NADPH oxidase inhibitor for the treatment of hearing loss and phantom hearing
#79Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH
#80Protein arrays and uses thereof
#81Neoplasia-Specific tNOX Isoforms and Methods
#82Methods and compounds to alter virus infection
#83Methods and compounds to alter virus infection
#84Autoimmune Conditions and NADPH Oxidase Defects
#85EXPRESSION QUANTIFICATION USING MASS SPECTROMETRY
#862031 Oxidoreductase
#87Method for positively detecting toxic material
#88Nitroreductase enzymes
#89Method of searching substrate having antidiabetic activity
#90Mitogenic oxygenase regulators
#91Method for detecting presence of toxic material within sample
#92Expression quantification using mass spectrometry
#93Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH
#94Protein arrays and uses thereof
#95Inducible fluorescence assay
#96Method of detecting the presence and/or progression of cancer
#97Expression quantification using mass spectrometry
#98Methods and kits for determining metabolic stability of compounds
#99Common ligand universal enzyme assay and compositions for use therein
#100Mitogenic oxygenase regulators
#101Oxidase
#102Mitogenic oxygenase regulators
#103Point-of-care device for the colorimetric determination of L-phenylalanine in biological samples
#104Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease